MX2010006310A - O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. - Google Patents
O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor.Info
- Publication number
- MX2010006310A MX2010006310A MX2010006310A MX2010006310A MX2010006310A MX 2010006310 A MX2010006310 A MX 2010006310A MX 2010006310 A MX2010006310 A MX 2010006310A MX 2010006310 A MX2010006310 A MX 2010006310A MX 2010006310 A MX2010006310 A MX 2010006310A
- Authority
- MX
- Mexico
- Prior art keywords
- desmethyl
- venlafaxine
- depressive disorder
- major depressive
- treating major
- Prior art date
Links
- 208000024714 major depressive disease Diseases 0.000 title abstract 3
- KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 208000011736 mal de Debarquement Diseases 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000006186 oral dosage form Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003890 succinate salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención provee métodos para tratar el trastorno depresivo mayor (MDD, por sus siglas en inglés); en general, los métodos comprenden administrar a un paciente que lo necesita una dosis diaria de aproximadamente 50 mg de o-desmetil-venlafaxina (ODV) o una cantidad equivalente de una sal farmacéuticamente aceptable de la misma; en ciertas modalidades, un paciente que necesita tratamiento se caracteriza por un diagnóstico primario de MDD; en algunas modalidades, la dosis se administra como una sola dosis diaria; en un conjunto de modalidades, los métodos incluyen administrar una forma de dosis oral que comprende sal de succinato de ODV.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2007/086986 WO2009075677A1 (en) | 2007-12-10 | 2007-12-10 | O-desmethyl-venlafaxine for treating major depressive disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010006310A true MX2010006310A (es) | 2010-08-31 |
Family
ID=39326191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010006310A MX2010006310A (es) | 2007-12-10 | 2007-12-10 | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110027324A1 (es) |
| AU (1) | AU2007362336A1 (es) |
| BR (1) | BRPI0722303A2 (es) |
| CA (1) | CA2708832A1 (es) |
| MX (1) | MX2010006310A (es) |
| TR (1) | TR201004720T1 (es) |
| WO (1) | WO2009075677A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012024576A2 (pt) * | 2010-03-31 | 2016-05-31 | Wockhardt Ltd | composição farmacêutica de liberação modificada compreendendo desvenlafaxina ou sais da mesma e processo para preparação da dita composição |
| CA2788526A1 (en) * | 2010-05-14 | 2011-11-17 | Alembic Limited | Extended release formulations of desvenlafaxine base |
| US20200000229A1 (en) * | 2018-06-28 | 2020-01-02 | Summit Product Development, LLC | Low Profile Cabinet Organizer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2008000249A (es) * | 2005-07-06 | 2008-03-18 | Sepracor Inc | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. |
| RU2007148195A (ru) * | 2005-07-15 | 2009-08-20 | Вайет (Us) | Пероральные дозированные формы о-десметилвенлафаксин сукцината повышенной биодоступности с отсроченным высвобождением |
-
2007
- 2007-12-10 US US12/747,096 patent/US20110027324A1/en not_active Abandoned
- 2007-12-10 CA CA2708832A patent/CA2708832A1/en not_active Abandoned
- 2007-12-10 AU AU2007362336A patent/AU2007362336A1/en not_active Abandoned
- 2007-12-10 MX MX2010006310A patent/MX2010006310A/es not_active Application Discontinuation
- 2007-12-10 WO PCT/US2007/086986 patent/WO2009075677A1/en not_active Ceased
- 2007-12-10 BR BRPI0722303-0A patent/BRPI0722303A2/pt not_active IP Right Cessation
- 2007-12-10 TR TR2010/04720T patent/TR201004720T1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0722303A2 (pt) | 2014-04-22 |
| CA2708832A1 (en) | 2009-06-18 |
| WO2009075677A1 (en) | 2009-06-18 |
| AU2007362336A1 (en) | 2009-06-18 |
| US20110027324A1 (en) | 2011-02-03 |
| TR201004720T1 (tr) | 2010-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| MX344476B (es) | Metodos de tratar trastornos pulmonares con formulaciones de amikacina liposomal. | |
| RU2013148721A (ru) | Комбинации соединений, ингибирующих акт и вемурафениба и способы их применения | |
| EA201590166A1 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| NZ604029A (en) | Methods of treating bladder cancer | |
| CA2883751A1 (en) | Methods of treating alzheimer's disease and pharmaceutical compositions thereof | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
| NZ597378A (en) | Treatment of multiple sclerosis with laquinimod | |
| IL189546A0 (en) | Therapy for the treatment of disease | |
| MXPA05007857A (es) | Moduladores derivados de indol de receptores nucleares de hormonas esteroideas. | |
| IL196425A (en) | Dosage unit for oral administration containing ibuprofen and pamotidine | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| RU2014150942A (ru) | Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона | |
| NZ591525A (en) | Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin | |
| RU2013127420A (ru) | Способы уменьшения психогенного или компульсивного переедания | |
| RU2012108439A (ru) | Способы лечения опухолей головного мозга | |
| BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
| JP2008534503A5 (es) | ||
| MX2013003523A (es) | Composicion farmaceutica de dosis baja. | |
| RU2012108144A (ru) | Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами | |
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| MX2012005497A (es) | Tivozanib y temsirolimus en combinacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |